Chaowalit Yuajit

Dr. Chaowalit Yuajit

Ubon Ratchathani University, Ubon Ratchathani, Thailand
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025
Verified
Journal Article
Open access
RTRuttiya Thongrung
Ruttiya Thongrung
SLSarawut Lapmanee
Sarawut Lapmanee
PBPenjai Thongnuanjan Bray
Penjai Thongnuanjan Bray
PSPatlada Suthamwong
Patlada Suthamwong
SDSuwaporn Deandee
Suwaporn Deandee
CYChaowalit Yuajit
Chaowalit Yuajit
Diabetic nephropathy is a leading cause of end-stage renal disease globally, with limited treatment options to prevent its progression. Gambogic acid (GA), a xanthone isolated from Garcinia hanburyi, has shown notable anti-oxidative, anti-inflammatory, and anti-proliferative properties. This study aimed to assess GA's renoprotective effects in a model of diabetic nephropathy mediated by low dose streptozotocin (STZ) combined with a high-fat diet, focusing on its potential to reduce oxidative stress and inflammation. Control-treated vehicle and STZ/high-fat diet-mediated diabetic rats were administered either the vehicle or 3 or 6 mg/kg of GA to assess its effects on renal inflammation, fibrosis, and oxidative stress. Renal histological changes were assessed, and markers for inflammation and oxidative stress, including I-κBα, p-p38/MAPK, and p-p65NF-κB pathways, were measured to explore the mechanisms of GA. Diabetic rats showed significant renal dysfunction, structural damage, and increased inflammation and fibrosis. Treatment with GA markedly improved renal structure and function. GA also reduced oxidative stress, increased I-κBα expression, and inhibited key signaling pathways, specifically p-p38/MAPK and p-p65NF-κB, involved in cellular inflammation. GA exhibits promising renoprotective effects in diabetic nephropathy by reducing oxidative stress and inflammation, supporting its potential as a natural therapeutic agent for diabetic renal disease.

15 June 2022 in Molecules
Verified
Journal Article
Open access
PDF file
NKNutchanard Khunpatee
Nutchanard Khunpatee
KBKanit Bhukhai
Kanit Bhukhai
VCVaranuj Chatsudthipong
Varanuj Chatsudthipong
CYChaowalit Yuajit
Chaowalit Yuajit
Abnormal cell proliferation and accumulation of fluid-filled cysts along the nephrons in polycystic kidney disease (PKD) could lead to a decline in renal function and eventual end-stage renal disease (ESRD). Gambogic acid (GA), a xanthone compound extracted from the brownish resin of the Garcinia hanburyi tree, exhibits various pharmacological properties, including anti-inflammation, antioxidant, anti-proliferation, and anti-cancer activity. However, its effect on inhibiting cell proliferation in PKD is still unknown. This study aimed to determine the pharmacological effects and detailed mechanisms of GA in slowing an in vitro cyst growth model of PKD. The results showed that GA (0.25–2.5 μM) significantly retarded MDCK cyst growth and cyst formation in a dose-dependent manner, without cytotoxicity. Using the BrdU cell proliferation assay, it was found that GA (0.5–2.5 μM) suppressed MDCK and Pkd1 mutant cell proliferation. In addition, GA (0.5–2.5 μM) strongly inhibited phosphorylation of ERK1/2 and S6K expression and upregulated the activation of phosphorylation of AMPK, both in MDCK cells and Pkd1 mutant cells. Taken together, these findings suggested that GA could retard MDCK cyst enlargement, at least in part by inhibiting the cell proliferation pathway. GA could be a natural plant-based drug candidate for ADPKD intervention.

3 October 2018 in The Journal of Physiological Sciences
Verified
Journal Article
Open access
PDF file
TBTipwadee Bunprajun
Tipwadee Bunprajun
CYChaowalit Yuajit
Chaowalit Yuajit
RNRattikarn Noitem
Rattikarn Noitem
VCVaranuj Chatsudthipong
Varanuj Chatsudthipong
This study aimed to investigate the effects of various types of exercise on organic anion transporter 3 (Oat3) function, a major transporter that plays a role in the secretion of a variety of drugs and endogenous compounds. Male Wistar rats were randomly allocated to non-exercise, exhaustive, acute and training exercise groups. The function of Oat3 was assessed by the uptake of [3H]-estrone sulfate ([3H]-ES) into rat renal cortical slices. Acute and training exercises had no effect on [3H]-ES uptake whereas a marked reduction in [3H]-ES uptake occurred immediately after exhaustive exercise. However, the reduction in Oat3 function was gradually recovered at 6 and 24 h after the exercise session. Importantly, the impairment of Oat3 function was associated with a decrease in renal Oat3 protein expression. Our results indicate that exhaustive exercise produces a significant impact on renal organic anion transport function, which in turn could alter the plasma level of drugs and compounds in the body.

31 May 2021 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
PVPeerachat Veeraphan
Peerachat Veeraphan
WCWarinthorn Chavasiri
Warinthorn Chavasiri
CMChatchai Muanprasat
Chatchai Muanprasat
VCVaranuj Chatsudthipong
Varanuj Chatsudthipong
CYChaowalit Yuajit
Chaowalit Yuajit

Verified
Journal Article
Open access
PDF file
Sarawut LapmaneeSarawut Lapmanee
Sarawut Lapmanee
JLJitpatima Lumsutti
Jitpatima Lumsutti
NCNatthawut - Charoenphon
Natthawut - Charoenphon
AIAnjaree Inchan
Anjaree Inchan
NBNittaya Boonmuen
Nittaya Boonmuen
CSChaiyos Sirithanakorn
Chaiyos Sirithanakorn
Chronic stress induces mood disturbances, disrupts gut barrier function, and promotes low-grade systemic inflammation. This study assessed the therapeutic effects of atomoxetine (ATX), escitalopram (ESC), cannabidiol (CBD), and CBD-loaded lipid nanoparticles (CBD/LNP) in male rats exposed to repeated restraint stress. Stressed rats exhibited a 2.03-fold increase in interleukin-6 and a 1.89-fold increase in TNF-α, a 1.20-fold decrease in brain-derived neurotrophic factor, a 1.36-fold decrease in osteocalcin, accompanied by alterations in gut metabolites, particularly short-chain fatty acids (SCFAs; from 155.3 to 94.83 μmol/L), polyamines (from 273.6 to 192.4 μmol/L), and bile acids (BAs; from 21.19 to 14.53 μmol/L), compared with the control group. Protein analysis revealed gut barrier disruption and microglial/macrophage activation, accompanied by reduced synaptic plasticity. ATX improved gut permeability and reduced glial activation but did not restore osteocalcin. ESC provided neuroimmune benefits with limited and BA gut restoration and modulated the gut–brain axis and improved anxiety-like behaviors, partly by altering gut microbiota and metabolites. CBD and CBD/LNP treatment restored intestinal barrier function, as indicated by intestinal permeability in the range of 1.15–1.61-fold. These treatments also normalized bile acids (1.0–1.38-fold) and osteocalcin (1.0–1.28-fold) and significantly reduced glial activation (0.63–1.12-fold) as opposed to the non-treated stressed group. All treatments were found to be effective in correcting SCFA and polyamine levels. Histological analysis confirmed that CBD/LNP, ATX, and ESC ameliorated tissue alterations. These findings highlight CBD/LNP as a promising intervention for stress-induced gut–brain–bone axis disruption, supporting its potential as a therapeutic alternative through modulation of microbiota-driven gut–brain communication in stress-associated disorders.

26 September 2025 in ACS Omega
Verified
Journal Article
Open access
NKNutchanard Khunpatee
Nutchanard Khunpatee
WSWanwisa Suwannaloet
Wanwisa Suwannaloet
PSPatlada Suthamwong
Patlada Suthamwong
SDSuwaporn Daendee
Suwaporn Daendee
Sarawut LapmaneeSarawut Lapmanee
Sarawut Lapmanee
CYChaowalit Yuajit
Chaowalit Yuajit
Interstitial inflammation is a major component of polycystic kidney disease (PKD) pathophysiology, driving renal cystogenesis progression. Gambogic acid (GA), a xanthone compound, exhibits antiproliferative, anti-inflammatory, and anticancer effects. GA inhibits in vitro renal cyst progression by inhibiting the cell proliferation pathway. However, its effect on cellular inflammation in PKD remains unclear. This study aimed to elucidate the detailed mechanisms by which GA inhibits inflammatory pathways to slow cyst growth in an in vitro PKD model. GA at 0.5-2.5 μM significantly retarded Madin-Darby canine kidney (MDCK) cyst growth in a dose-dependent manner. Real-time RT-PCR revealed that GA (2.5 μM) suppressed IL-6 and TNF-α mRNA expression. Notably, GA strongly inhibited p38 and p65NF-κB phosphorylation in both dose- and time-dependent manners in MDCK and Pkd1 mutant cells. Collectively, these findings suggest that GA may retard MDCK cyst enlargement partly by inhibiting inflammation pathways. GA may represent a promising plant-based drug candidate for treating autosomal dominant polycystic kidney disease.